The EU had previously approved two vaccines for protecting ... "This approval of the first mRNA vaccine against RSV clearly shows the importance of innovation when it comes to protecting the ...

GSK plc GSK has announced the approval of the European Commission (EC) for the expanded use of its respiratory syncytial ...

The company's vaccine consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein.

The EU follows the US in approving the use of the shot in the younger age range in people with conditions like chronic ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

(Family Features) Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One ...

CORRECTION: An earlier version of this story misstated the number of RSV vaccines ... after the vaccine had been approved. “There were a lot of kinks last year to work out for the first time ...

RSV is a highly contagious seasonal virus that can cause severe symptoms in infants and the elderly -- one in 20 of whom ...